RNS Number:8124L
IDMoS plc
09 November 2006


For immediate release                                            9 November 2006

                      IDMoS plc ("IDMoS" or the "Company")
              Placing of 2.1 million shares to raise #1.9 million

IDMoS plc (AIM: IDO), the specialist in disease detection and monitoring
technology, today announces the placing (the "Placing") of 2.1 million new
ordinary shares of 5p each ("new Ordinary Shares") at 90 pence per share. The
new Ordinary Shares, which represent approximately 13 per cent of the current
issued ordinary share capital of the Company, have been placed by Nomura Code
Securities Limited, on behalf of the Company, with new and existing
institutional investors as well as the Directors. The Directors of the Company
participated in the Placing, and between them subscribed for shares to a value
of #100,000. The Placing in total raised #1.9 million.

The Company also announces today its Preliminary Results for the year ended 31
July 2006 and the expansion of its dental product range to include a new Caries
Detection Device ("CDD"). Further details of these are set out in a separate
announcement.

The net proceeds of the Placing will be used to meet the additional funding
requirements arising from the investment in the development of the CDD, the
launch of the CDD and Caries Management Support System, and to provide resources
for IDMoS's growing medical activities.

The Placing is conditional, inter alia, on admission of the new Ordinary Shares
to trading on AIM and the approval by shareholders at an Extraordinary General
Meeting to be held by the Company. A circular will be sent to shareholders
shortly together with the notice of EGM.

Application will be made for the new Ordinary Shares to be admitted to trading
on AIM and it is expected that trading in the new Ordinary Shares, which will
rank pari passu in all respects with the existing ordinary shares in the
Company, will commence on AIM by 12 December 2006.

Stephen Westwood, Chief Executive, said:

"I would like to thank our investors for supporting us in this Placing. This new
funding will provide us with the flexibility to enable us to take the business
forward to the next stage, to commercially launch both the Caries Management
Support System and our newly innovated Caries Detection Device. It will also
enable us to work on further expanding our product range to include the 3D CMSS.
This is an exciting phase in the Company's growth and we look forward to meeting
these objectives."


                                      ENDS


For further information, please contact:
IDMoS plc
Stephen Westwood                                                    01382 598440

Buchanan Communications
Diane Stewart/Tim Anderson                                         020 7466 5000







                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
MSCUUGRGGUPQGGB

Idmos (LSE:IDO)
Gráfica de Acción Histórica
De May 2024 a Jun 2024 Haga Click aquí para más Gráficas Idmos.
Idmos (LSE:IDO)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024 Haga Click aquí para más Gráficas Idmos.